Irish Peptide Research logo
Irish Peptide Research

GLP-1 and peptide research compounds

← Back to blog

Peptide · Research review

BPC-157 and Tissue Repair Signaling: A Research Review

Posted: October 2026

BPC-157 (Body Protection Compound-157) is a partial sequence of a gastric protein studied extensively in preclinical models. Irish Peptide Research supplies BPC-157 as a research compound in Ireland for laboratory and in vitro research use only.

The compound has been investigated in vitro and in animal models for its apparent effects on angiogenesis, nitric oxide signaling, and growth factor expression related to tissue repair.

Mechanism of Action

Studies have investigated how BPC-157 may interact with the nitric oxide system, vascular endothelial growth factor (VEGF), and fibroblast activity. In vitro models suggest potential modulation of these pathways, though mechanism remains under investigation.

Preclinical Research Context

Laboratory studies have examined BPC-157 in models of tendon, muscle, and gastrointestinal tissue. This research is for laboratory and in vitro research use only and is not intended for human use.

Sources: Sikiric et al 2010
All products listed on this website are supplied strictly for laboratory, analytical, and in vitro research purposes only. Not intended for human or animal consumption.

Research Digest

Weekly summary of new peptide and GLP-1 research. No spam — unsubscribe any time.